FDA OKs RF Pain-Management System for Use in People with Metal Implants

The FDA removed the metal-implant contraindication for the Provant Therapy System, making Provant available for use in patients with metallic joint-replacement components and internal-fixation devices. Provant  uses pulsed radio-frequency (RF) waves to treat postoperative pain and edema in superficial soft tissue. The prescription device, which is used by patients at home, includes an RF generator that induces the production of endogenous opioids in keratocytes. Scott Brooks, CEO of Provant’s manufacturer, Regenesis Biomedical, said the company is now reaching out to orthopaedic and rehabilitation clinicians to educate them on the benefits of the therapy.

Tags: , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: